Advertisement

Topics

Daiichi Sankyo takes option on diabetes stem cell start-up

04:53 EST 11 Jan 2019 | pharmaphorum

Japan’s Daiichi Sankyo has joined an open innovation research initiative that will try to develop a therapy for type 1 diabetes based on insulin-producing cells. The drugmaker has teamed up with Tokyo Institute of Technology for the project, which...

Original Article: Daiichi Sankyo takes option on diabetes stem cell start-up

NEXT ARTICLE

More From BioPortfolio on "Daiichi Sankyo takes option on diabetes stem cell start-up"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Endocrine Disorders
Endocrine disorders are grouped into two categories: hormone imbalance - when a gland produces too much or too little of an endocrine hormone development of lesions (such as nodules or tumors) in the endocrine system, which may or may not affect...